BIOA
BIOA
NASDAQ · Pharmaceuticals

Bioage Labs Inc

$16.43
+0.32 (+1.99%)
As of Mar 25, 2:16 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 7 64%
Hold 4 36%
Sell 0 0%
Price Target
Analyst Price Target -20.0% upside
Low Target $9.99
Average Target $13.14
High Target $19.07
Current Price $16.43
Current
$16.43
Target
$13.14
$9.99 $13.14 avg $19.07
Scenario Analysis
Bear Case
$9.99
-39.2%
Low target
Base Case
$13.14
-20.0%
Avg target
Bull Case
$19.07
+16.1%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$24.00
-31.5% from high
52-Week Low
$2.88
+470.5% from low
Target vs 52W High
$13.14
-45.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%